Hormone Therapy for Prostate Cancer May Trigger Brain Changes and Memory Problems
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
20 articles
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.
A completed RCT tests whether treating insomnia with CBT-I can improve cognition and slow amyloid buildup in adults aged 60โ85.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
Duke University study tests whether targeted brain stimulation can reverse age-related cognitive decline and improve working memory.
A completed pilot trial tests adapted Dialectical Behavior Therapy to reduce suicidality in aging family caregivers of AD/ADRD patients.
A completed RCT tests whether trained non-clinicians can guide self-help CBT for generalized anxiety disorder in seniors.
A pilot RCT tested whether a smartphone app could improve quality of life and treatment adherence in HIV-positive patients aged 60+.
A VA-sponsored trial tested whether the blood pressure drug prazosin could remove toxic proteins linked to CTE and Alzheimer's in combat veterans.
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
The EPICURO trial tests MERIVAยฎ turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
A Phase 1 trial of AV-1959R, an Aฮฒ-targeting vaccine, tests safety and antibody generation in healthy adults aged 40โ60.
A Phase 2 open-label trial explores whether an approved immune drug can raise frataxin protein levels and slow neurological decline in Friedreich Ataxia.
A completed Canadian platform trial enrolls 354 at-risk adults in a multidomain online brain health program targeting dementia prevention.
Individualized brain training targets specific cognitive weaknesses in adults over 50 with HIV-associated thinking problems.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.